Business Description
Pulike Biological Engineering Inc
ISIN : CNE1000025N0
Share Class Description:
SHSE:603566: Class ACompare
Compare
Traded in other countries / regions
603566.China IPO Date
2015-05-18Description
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 313.43 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1121.21 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.35 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.9 | |||||
| 3-Year EBITDA Growth Rate | -5.6 | |||||
| 3-Year EPS without NRI Growth Rate | -2.9 | |||||
| 3-Year Book Growth Rate | 13.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 86.94 | |||||
| 9-Day RSI | 77.71 | |||||
| 14-Day RSI | 71.35 | |||||
| 6-1 Month Momentum % | -9.74 | |||||
| 12-1 Month Momentum % | -35.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3 | |||||
| Quick Ratio | 2.58 | |||||
| Cash Ratio | 1.47 | |||||
| Days Inventory | 152.54 | |||||
| Days Sales Outstanding | 136.14 | |||||
| Days Payable | 109.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.26 | |||||
| Dividend Payout Ratio | 1.4 | |||||
| 3-Year Dividend Growth Rate | 48.1 | |||||
| Forward Dividend Yield % | 3.26 | |||||
| 5-Year Yield-on-Cost % | 7.53 | |||||
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | 3.44 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.28 | |||||
| Operating Margin % | 15.19 | |||||
| Net Margin % | 11.66 | |||||
| FCF Margin % | 0.29 | |||||
| ROE % | 4.97 | |||||
| ROA % | 4.17 | |||||
| ROIC % | 7.96 | |||||
| ROC (Joel Greenblatt) % | 11.88 | |||||
| ROCE % | 5.39 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 51.08 | |||||
| PE Ratio without NRI | 42.93 | |||||
| Shiller PE Ratio | 36.22 | |||||
| PEG Ratio | 5.05 | |||||
| PS Ratio | 5.77 | |||||
| PB Ratio | 2.52 | |||||
| Price-to-Tangible-Book | 2.83 | |||||
| Price-to-Free-Cash-Flow | 3239.96 | |||||
| Price-to-Operating-Cash-Flow | 27.78 | |||||
| EV-to-EBIT | 41.32 | |||||
| EV-to-EBITDA | 41.32 | |||||
| EV-to-Revenue | 5.29 | |||||
| EV-to-FCF | 1543.99 | |||||
| Price-to-Projected-FCF | 3.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.34 | |||||
| Price-to-Graham-Number | 2.32 | |||||
| Price-to-Net-Current-Asset-Value | 8.2 | |||||
| Price-to-Net-Cash | 39.84 | |||||
| Earnings Yield (Greenblatt) % | 2.42 | |||||
| FCF Yield % | 0.05 | |||||
| Forward Rate of Return (Yacktman) % | 6.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulike Biological Engineering Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,181.272 | ||
| EPS (TTM) (Â¥) | 0.39 | ||
| Beta | 1.38 | ||
| Volatility % | 37.17 | ||
| 14-Day RSI | 71.35 | ||
| 14-Day ATR (Â¥) | 0.73998 | ||
| 20-Day SMA (Â¥) | 17.744 | ||
| 12-1 Month Momentum % | -35.54 | ||
| 52-Week Range (Â¥) | 12.89 - 28.8 | ||
| Shares Outstanding (Mil) | 346.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulike Biological Engineering Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulike Biological Engineering Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulike Biological Engineering Inc Frequently Asked Questions
What is Pulike Biological Engineering Inc(SHSE:603566)'s stock price today?
The current price of SHSE:603566 is ¥19.92. The 52 week high of SHSE:603566 is ¥28.80 and 52 week low is ¥12.89.
When is next earnings date of Pulike Biological Engineering Inc(SHSE:603566)?
The next earnings date of Pulike Biological Engineering Inc(SHSE:603566) is .
Does Pulike Biological Engineering Inc(SHSE:603566) pay dividends? If so, how much?
The Dividend Yield %  of Pulike Biological Engineering Inc(SHSE:603566) is 3.26% (As of Today), Highest Dividend Payout Ratio of Pulike Biological Engineering Inc(SHSE:603566) was 1.5. The lowest was 0.34. And the median was 0.79. The  Forward Dividend Yield % of Pulike Biological Engineering Inc(SHSE:603566) is 3.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers